Mayuko Tani
Kanazawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task Force.
Journal: Open forum infectious diseases
Published: March 11, 2023
Diagnostic significance of secondary bacteremia in patients with COVID-19.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: October 15, 2022
Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study.
Journal: BMC pulmonary medicine
Published: September 06, 2022
Long-Term Survival of Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Monotherapy in Real-World Settings.
Journal: Clinical lung cancer
Published: November 10, 2021
DOCK2 is involved in the host genetics and biology of severe COVID-19.
Journal: Nature
Published: October 26, 2021
Primary A (H1N1) pdm09 Influenza Pneumonia Diagnosed on Reverse Transcription-polymerase Chain Reaction (RT-PCR) of Bronchoalveolar Lavage Fluid but not Rapid Tests with Nasopharyngeal Swabs.
Journal: Internal medicine (Tokyo, Japan)
Published: June 02, 2015
Transformation to small-cell lung cancer following treatment with EGFR tyrosine kinase inhibitors in a patient with lung adenocarcinoma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 18, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026